Aurobindo Pharma USA Inc recalls Cinacalcet Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
- Products
-
- Cinacalcet Tablets
- Company
- Aurobindo Pharma USA Inc
- Where it was sold
-
USA Nationwide
Nationwide
- Units affected
- 102576 bottles
- About this recall
- Cinacalcet Tablets, 30 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-831-30); b) 500-count HDPE bottle (NDC 65862-831-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.